Apogee Therapeutics Inc (APGE) PT Lowered to $82 at RBC Capital Mar 2, 2026 03:49PM
RBC Capital Downgrades Apogee Therapeutics Inc (APGE) to Sector Perform Jan 22, 2026 05:06AM
RBC on Apogee Therapeutics Inc (APGE): 'we remain bullish on APGE's outlook' Jan 6, 2026 10:16AM
Where can biotech stocks go from here? RBC answers Nov 16, 2025 03:00PM
Apogee Therapeutics Inc (APGE) PT Raised at RBC Capital on Pipeline Potential Nov 3, 2025 08:51AM


Sep 25, 2025 03:03AM RBC Capital Starts Apogee Therapeutics Inc (APGE) at Outperform